The UK and the European Union have agreed on a major new trade and cooperation deal, marking a significant shift in the post-Brexit relationship and paving the way for closer economic and security ties.
With only 2 months to go, Nicholas Kelly, CEO, Axela Ltd, discusses what needs to be done now in order to prepare healthcare services for the post-Brexit era.
The total financial cost of COVID-19 won’t be known until after the crisis is over - but we can look into the available data and piece something together.
John Bell, chartered accountant, insolvency practitioner and Director of Clarke Bell, shares his advice for contractors who are faced with the decision of closing down their Personal Service Company (PSC).
Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.
Prof Monica Di Luca, President, European Brain Council, sheds light on the greater impact of Brexit in terms of health and brain research being up for negotiation.
Dr Benjamin Martill, Associate at LSE IDEAS & Lecturer, University of Edinburgh, asks if there is no time for politics in the war against COVID-19 and provides a compelling response.
PMAC, Mental Health Training & Wellbeing Professionals, discuss the potential impact of Brexit on mental health, with a specific focus on immigration and family separation.
René Seifert, co-founder of TrueProfile.io, suggests that now is the time for healthcare regulators and NHS recruiters to turn to Blockchain-enabled identity verification services as post-Brexit ‘Global Britain’ takes off.
